Active

PAMLAB

Switched

BE0461543816

Rechtspersoon Private limited company

Rue de Libin,Smuid 27, 6890 Libin Activiteiten van medisch specialisten

Active for

28 year, 11 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ 5,077

▲ 599% vs 2024

Profit

Caution

€ -21,930

▲ 31% vs 2024

Debts

Low

€ 7,327

▼ 22% vs 2024

PAMLAB from Libin, company number BE0461543816, closed financial year 2025 with a result of € -21,930 after tax. For that financial year PAMLAB recorded a gross margin of € 5,077 and equity of € 834,301. Compared with financial year 2024, the result moved from € -31,638 to € -21,930. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at PAMLAB?

What happened at PAMLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 21,930. filed late Source: NBB ↗
  • Start of the company according to the CBE. KBO

In short

From € 202,194 profit in 2021 to € 21,930 loss in 2025.

Paid € 204,174 in corporate taxes since 2021.

Best year ever: 2022, with € 240,140 profit.

Paid out € 573,207 in dividends to the owners in total.

A new publication or filing at PAMLAB? We notify you, reason included.

Follow PAMLAB

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Antonio Seco de Seixas Pereira
PAMLAB

Behind PAMLAB is Antonio Seco de Seixas Pereira.

See the full network in the app

Directors

According to the 2025 annual accounts

Antonio Seco de Seixas Pereira

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Libin,Smuid 27

6890 Libin

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0461.543.816
VAT number
BE 0461.543.816
Registered office
Rue de Libin,Smuid 27, 6890 Libin
Names & denominations
PAMLAB
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
26 September 1997
Peppol
Active · Active since 25 Nov 2025
Activities · NACE

Activiteiten van medisch specialisten

Frequently asked questions

What is the enterprise number of PAMLAB?
The enterprise number of PAMLAB is BE0461543816.
What is the address of PAMLAB?
The registered office of PAMLAB is located at Rue de Libin,Smuid 27, 6890 Libin.
When was PAMLAB founded?
PAMLAB was founded on 26 September 1997.
What is the main activity of PAMLAB?
The main activity of PAMLAB is "Activiteiten van medisch specialisten" (NACE code 86220).
Does PAMLAB have a website?
No website is currently known for PAMLAB.
How much profit did PAMLAB make in 2025?
PAMLAB recorded a loss after taxes of € 21,930 in financial year 2025.
What is the revenue of PAMLAB?
As a small company, PAMLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 5,077.
Where can I find the annual accounts of PAMLAB?
PAMLAB files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PAMLAB?
According to the 2025 annual accounts, the directors of PAMLAB are: Antonio Seco de Seixas Pereira.
Who owns PAMLAB?
Behind PAMLAB is Antonio Seco de Seixas Pereira.